No chemo (n = 206) | Chemo (n = 67) | Univariate analysis p-value | |
---|---|---|---|
No. (%) | No. (%) | Chi Square association test | |
Primary site | |||
Lower extremity | 136 (66%) | 50 (75%) | 0.224* |
Upper extremity | 42 (20%) | 9 (13%) | |
Thorax | 14 (7%) | 6 (9%) | |
Trunk | 13 (6%) | 1 (2%) | |
Overlapping | 1 (1%) | 1 (2%) | |
Tumor size (≥ 8 cm) | |||
< 8 cm | 76 (37%) | 18 (27%) | 0.133 |
≥ 8 cm | 130 (63%) | 49 (73%) | |
Sex | |||
Female | 82 (40%) | 28 (42%) | 0.774 |
Male | 124 (60%) | 39 (58%) | |
Grade (FNCLCC) | |||
2 | 46 (22%) | 17 (25%) | 0.608 |
3 | 160 (78%) | 50 (75%) | |
Radiation | 170 (83%) | 50 (75%) | 0.156 |
Surgery | 203 (99%) | 64 (96%) | 0.143 |
Age | |||
≥T70 | 90 (43.7%) | 4 (6%) | < 0.001* |
< 70 | 116 (56.3%) | 63 (94%) | |
ECOG performance status | |||
0 | 56 (27%) | 14 (21%) | 0.644* |
1 | 117 (57%) | 49 (73%) | |
2 | 31 (15%) | 4 (6%) | |
3 | 2 (1%) | 0 (0%) |